In developing this automated cell therapy processing platform, Limula’s founders aim to create a disruptive production ...

Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced ...

Interestingly, upregulation of both CD69 and PD-1 was observed on tumor-infiltrating CD8+ T cells following both beta-emitting and alpha-emitting radiotherapies, in contrast to untreated tumors. While ...

LIfT BioSciences presents latest data on its first-in-class Immunomodulatory Alpha Neutrophils at International Society for Cell and Gene Therapy London, 19 May 2025- LIfT BioSciences, ('LIfT' or 'the ...

supporting potential treatment for sickle cell disease and beta thalassemia. Editas Medicine announced promising new data on May 14, 2025, demonstrating effective gene editing levels for HBG1/2 ...

Android 16 QPR1 beta is expected to debut the new Material 3 Expressive design language. The upcoming build is expected to include several new design changes, including the new Quick Settings ...

Patient Reported Data Show an Improved Awareness of Onset of Hypoglycemia, a Reduction of Fear of Hypoglycemic Events and a Reduction in Distress Associated with Managing Their Type 1 Diabetes LONDON, ...

Their work began back in 2015, focusing on ways to make the body produce more of its own insulin-producing cells, known as beta cells. These cells are crucial for controlling blood sugar levels ...

(Representational Image/Freepik) As hostilities between India and Pakistan escalate, investors should consider smart beta funds to protect the downside risks and generate alpha. These funds choose ...